Brain Connectivity as a Biomarker of Response to Transcranial Stimulation by Continuous Current in Patients With Stroke

Stroke Clinical Trial

Official title:

Brain Connectivity as a Biomarker of Response to Transcranial Stimulation by Continuous Current in Patients With Stroke: Sham Controlled, Randomized Clinical Trial

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04752800
• Other study ID #: EEGtDCSAVC
• Status: Not yet recruiting
• Phase: N/A
• Start date: May 2022
• Est. completion date: December 2022

Study information

• Verified date: May 2022
• Source: Federal University of Paraíba
• Contact: Suellen Andrade
• Phone: 83 99937-1471
• Email: suellenandrade[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

A randomized, double-blind, sham-controlled clinical trial will be conducted with 30 people with stroke, recruited at a referral hospital in João Pessoa. After recruitment they will be randomized into two groups: Group 1 - active stimulation and group - 2 sham stimulation. Participants will receive 10 sessions of ETCC, for 20 minutes, on alternate days (3 times a week), where the electrodes will be positioned over the primary motor cortex. 3 minutes of EEG at rest will be taken from each participant, and they will be instructed not to be actively involved in any cognitive or mental activity. In the first and last meetings, evaluations will be carried out, the outcomes evaluated will be: motor function, quality of life and functional connectivity.

Description:

Previous studies analyzed by systematic reviews suggest that the effects of ETCC may vary between subjects, where some stroke patients may not receive any additional benefits from therapy. Thus, it is necessary to use a biomarker that manages to elect those who will possibly benefit from the electric current. Therefore, the objective of this study is to investigate whether the EEG measures of functional connectivity of the target network of the stimulation are associated with the response to ipsilesional anodic ETCC in patients with stroke in the late subacute phase. as well as to observe if these findings can be associated with a clinical improvement of the patient. For that, a randomized, double-blind, sham-controlled clinical trial will be carried out with 30 people with stroke, recruited at a referral hospital in joão Pessoa.

After recruitment they will be randomized into two groups: Group 1 - active stimulation and group - 2 sham stimulation. Participants will receive 10 sessions of ETCC, for 20 minutes, on alternate days (3 times a week), where the electrodes will be positioned over the primary motor cortex. 3 minutes of EEG at rest will be taken from each participant (Eyes open and eyes closed), and they will be instructed not to be actively involved in any cognitive or mental activity. In the first and last meetings, evaluations will be carried out, the outcomes assessed will be: motor function, quality of life and functional connectivity.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 60
• Est. completion date: December 2022
• Est. primary completion date: September 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• Have had a single episode of unilateral, ischemic stroke, in middle cerebral artery proven by means of magnetic resonance imaging or computed tomography;

• Young adult individuals, over 18 years old;

• Both sexes;

• Patients in late subacute stage. Late sub-acute stage will be considered for patients between 3 and 6 months after stroke;

• Mild to moderate patients with a Fugl-Meyer score >85 points;

• Patients with mild to moderate degree of injury severity (NIHHS <17 points);

• Presentation of up to 4 points on the Rankin scale.

Exclusion Criteria:

• Use of drugs that modulate the activity of the Central Nervous System;

• Carriers of implanted metallic or electronic devices; cardiac pacemaker;

• habitual use of drugs or alcohol;

• Epilepsy history report; gestation; people with traumatic brain injury or tumors.

Related Conditions & MeSH terms

• Stroke

Intervention

Device:
• Direct Current Transcranial Stimulation - tDCS
Intervenção Ativa
• Sham Intervention
Direct Current Transcranial Stimulation - Sham Intervention

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Federal University of Paraíba

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Motor function	For the analysis of the primary outcome, the fulgl-Meyer evaluation scale will be used.; The scale consists of a cumulative numerical scoring system that assesses aspects related to range of motion, pain, sensitivity, motor function of the upper and lower extremities, in addition to coordination and speed.	Baseline and after 3 weeks
Secondary	Change in quality of life	To assess quality of life, the SF-36 questionnaire will be used, which is a multidimensional instrument, easy to administer and understand, translated and validated in Brazil, consisting of 36 items, encompassed in 8 scales: functional capacity, physical aspects, pain, state general health, vitality, social aspects, emotional aspects and mental health. It has a maximum final score of 100 points, where the higher the score, the greater the health status.	Baseline and after 3 weeks
Secondary	Functional Connectivity	For the EEG record, the actiCHamp32 model, Brain Products GmbH®, with 32 electrodes will be used. During data collection, participants will be seated in a comfortable chair, where they will be instructed to keep their gaze turned to a fixation point, avoiding talking or moving, these measures will be adopted to try to minimize the possible artifacts that may exist in the EEG record. Participants will also be instructed not to engage in any cognitive or mental activity during the collection period. The data will be collected in an environment conducive to the acquisition (silent place, with adequate lighting) where only the participant and the researcher responsible for the collection will be present.	Baseline and after 3 weeks